Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses ongoing clinical trials that will establish a clinical role for molecular risk factors in prostate cancer at ASCO GU 2016.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content